A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With Taxanes

NCT00277043 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Supportive
Ill-defined Sites

Interventions

DRUG: paclitaxel, docetaxel, taxane
DRUG: taxane

Sponsor

New Mexico Cancer Research Alliance